Chiba Yuhei, Fujishiro Hiroshige, Ota Kazumi, Kasanuki Koji, Arai Heii, Hirayasu Yoshio, Sato Kiyoshi, Iseki Eizo
PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine, Tokyo, Japan; Department of Psychiatry, Juntendo University School of Medicine, Tokyo, Japan; Department of Psychiatry, Yokohama City University School of Medicine, Kanagawa, Japan.
Int J Geriatr Psychiatry. 2015 Mar;30(3):316-23. doi: 10.1002/gps.4144. Epub 2014 May 20.
It is well known that Alzheimer's disease (AD)-type pathology is commonly present in dementia with Lewy bodies (DLB) brains and that the degree of AD-type pathology has an influence on the clinical characteristics of DLB. Although significant hypometabolism in the temporoparietal/precuneus on [(18)F]fluoro-d-glucose ((18)F-FDG) positron emission tomography (PET) scans is considered to support a diagnosis of AD, some DLB patients also exhibit this metabolic pattern. The clinical significance of the metabolic pattern on DLB remains unknown.
Twenty-three DLB patients, 10 AD patients, and 11 controls underwent (18)F-FDG PET scans. According to the degree of hypometabolism in the parietal/precuneus regions, representing the AD-like metabolic pattern, 12 patients were placed in the DLB-AD(+) group and 11 patients were placed in the DLB-AD(-) group. The demographics and clinical variables were compared among the four groups.
In addition to the parietal/precuneus regions, the DLB-AD(+) group exhibited significantly greater posterior cingulate hypometabolism than the DLB-AD(-) group, although occipital metabolism did not differ. The prevalence of visual hallucinations and extracampine hallucinations, and the Bender-Gestalt test score were significantly higher in the DLB-AD(+) group than the DLB-AD(-) group, although there were no differences in the demographics and other examined clinical variables between the two DLB groups. These clinical differences were absent in the DLB-AD(-) group, AD group, and controls.
Parietal/precuneus hypometabolism may be associated with clinical characteristics in DLB patients. Further multiple imaging modalities that are sensitive to AD-type pathology are needed to reveal the neurobiological basis of the AD-like metabolic pattern.
众所周知,阿尔茨海默病(AD)型病理改变在路易体痴呆(DLB)患者脑内普遍存在,且AD型病理改变的程度会影响DLB的临床特征。虽然[¹⁸F]氟代脱氧葡萄糖(¹⁸F-FDG)正电子发射断层扫描(PET)显示颞顶叶/楔前叶明显代谢减低被认为支持AD的诊断,但部分DLB患者也表现出这种代谢模式。DLB患者这种代谢模式的临床意义尚不清楚。
23例DLB患者、10例AD患者及11名对照者接受了¹⁸F-FDG PET扫描。根据顶叶/楔前叶区域代谢减低程度(代表AD样代谢模式),将12例患者分为DLB-AD(+)组,11例患者分为DLB-AD(-)组。比较四组的人口统计学和临床变量。
除顶叶/楔前叶区域外,DLB-AD(+)组后扣带回代谢减低程度显著高于DLB-AD(-)组,而枕叶代谢无差异。DLB-AD(+)组视幻觉和域外幻觉的发生率以及本德尔格式塔测验得分显著高于DLB-AD(-)组,尽管两个DLB组在人口统计学和其他检查的临床变量方面无差异。DLB-AD(-)组、AD组和对照组无这些临床差异。
顶叶/楔前叶代谢减低可能与DLB患者的临床特征相关。需要进一步采用对AD型病理改变敏感的多种成像方式,以揭示AD样代谢模式的神经生物学基础。